Viral infections induce higher morbidity and mortality in older people than in younger individuals. Based on both experimental and clinical studies, this disease burden is thought to be due to declining immune responses. However, our published work supported by the last cycle of the award challenges this paradigm as we found that older mice exhibit dysregulated immune responses during viral infection that induce immune pathology. This dysregulation consists of exaggerated IL-17 responses produced by natural killer T (NKT) cells, innate immune lymphocytes that respond rapidly to pathogens, coupled to defective type I interferon (IFN) responses by plasmacytoid dentritic cells (pDCs), sentinel immune cells that aid viral clearance. This defective viral clearance synergizes with the age-elevated IL-17 responses leading to severe liver inflammation and death. During non-lethal systemic viral infections, exaggerated inflammatory responses (i.e., IL-6 production) by NKT-cells coupled with defective type I IFN responses by pDCs induce an inflammatory environment that skews adaptive immune CD4+ T cells to an IL-17 producing phenotype. We have also observed the age-elevated IL-17 response coupled to defective type I IFNs in other viral infections such as in localized influenza lung infections. Here, we propose to study the underlying cellular and molecular mechanisms for dysregulation of immune responses with aging by using murine models to determine 1) if exaggerated inflammatory responses by NKT cells coupled to defective pDC responses are critical for the generation of IL-17 anti-viral CD4+ T cells during systemic herpes viral infections with aging;and 2) whether exaggerated IL-17 responses by aged NKT cells coupled with impaired type I IFN responses by pDCs also induce immune pathology during influenza viral lung infection. Our work will greatly differ from mainstream research in the field and may lead to novel anti-inflammatory therapies to improve immunity to viral infections with aging.
Current paradigms indicate that older people suffer from viral infections more than young people due to declining immune function. However, our studies show that in aged mice the course of viral infection is affected due to dysregulated immune responses. We propose to examine the factors that, with aging, lead to both exaggerated and defective immune responses to viral infection, which could lead to novel therapies to improve the outcome of viral infections in older people.
|Elpek, Kutlu G; Cremasco, Viviana; Shen, Hua et al. (2014) The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells. Cancer Immunol Res 2:655-67|
|Mori, Daniel N; Kreisel, Daniel; Fullerton, James N et al. (2014) Inflammatory triggers of acute rejection of organ allografts. Immunol Rev 258:132-44|
|Song, Yang; Shen, Hua; Du, Wei et al. (2013) Inhibition of x-box binding protein 1 reduces tunicamycin-induced apoptosis in aged murine macrophages. Aging Cell 12:794-801|
|Wong, Christine; Goldstein, Daniel R (2013) Impact of aging on antigen presentation cell function of dendritic cells. Curr Opin Immunol 25:535-41|
|Shen, Hua; Kreisel, Daniel; Goldstein, Daniel Robert (2013) Processes of sterile inflammation. J Immunol 191:2857-63|
|Goldstein, Daniel R (2012) Role of aging on innate responses to viral infections. J Gerontol A Biol Sci Med Sci 67:242-6|
|Decman, Vilma; Laidlaw, Brian J; Doering, Travis A et al. (2012) Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J Immunol 188:1933-41|
|Song, Yang; Shen, Hua; Schenten, Dominik et al. (2012) Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 32:103-9|
|Leng, Jin; Stout-Delgado, Heather W; Kavita, Uma et al. (2011) Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection. Vaccine 29:8147-55|
|Du, Wei; Shen, Hua; Galan, Anjela et al. (2011) An age-specific CD8+ T cell pathway that impairs the effectiveness of strategies to prolong allograft survival. J Immunol 187:3631-40|
Showing the most recent 10 out of 18 publications